False positive diagnosis on (131)iodine whole-body scintigraphy of differentiated thyroid cancers

Endocrine. 2016 Sep;53(3):626-35. doi: 10.1007/s12020-015-0750-3. Epub 2015 Oct 26.

Abstract

(131)Iodine is used both to ablate any residual thyroid tissue or metastatic disease and to obtain whole-body diagnostic images after total thyroidectomy for differentiated thyroid cancer (DTC). Even though whole-body scan is highly accurate in showing thyroid residues as well as metastases of DTC, false positive results can be found, possibly leading to diagnostic errors and unnecessary treatments. This paper reviews the physiological and pathological processes involved as well as the strategy to recognize and rule out false positive radioiodine images.

Keywords: 131Iodine; Differentiated thyroid cancer; Metastatic thyroid cancer; Natrium/iodide symporter; Radioiodine uptake; Thyroid scintigraphy; Whole-body scintigraphy.

Publication types

  • Review

MeSH terms

  • False Positive Reactions
  • Humans
  • Iodine Radioisotopes
  • Radionuclide Imaging / methods*
  • Thyroid Gland / diagnostic imaging*
  • Thyroid Neoplasms / diagnostic imaging*
  • Whole Body Imaging / methods*

Substances

  • Iodine Radioisotopes